Table I Index
Table of Contents
|
Table I - 20 Elkhart Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 569 | 318.3 | 277 | 359.3 | 292 | 292.5 |
| Oral cavity and pharynx | 17 | 10.1** | 10 | 13.1** | 7 | 7.8** |
| Lip | * | # | * | # | * | # |
| Tongue | 5 | 3.2** | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | 5 | 2.8** | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 89 | 46.8 | 51 | 63.7 | 38 | 35.7 |
| Esophagus | 5 | 3.1** | 5 | 6.7** | * | # |
| Stomach | 5 | 2.0** | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 39 | 20.0 | 22 | 27.3 | 17 | 16.1** |
| Rectum and rectosigmoid | 22 | 11.6 | 10 | 12.2** | 12 | 10.7** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 8 | 4.6** | 5 | 6.5** | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 104 | 61.3 | 69 | 89.7 | 35 | 38.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 6 | 3.5** | * | # | * | # |
| Lung and bronchus | 97 | 57.4 | 65 | 84.5 | 32 | 35.2 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 6 | 3.6** | * | # | * | # |
| Melanoma of the skin | 5 | 2.9** | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 108 | 59.3 | * | # | 107 | 106.7 |
| Female genital system | 52 | 28.6 | -- | -- | 52 | 52.7 |
| Cervix uteri | 6 | 2.9** | -- | -- | 6 | 5.7** |
| Corpus uteri | 34 | 19.6 | -- | -- | 34 | 36.0 |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 8 | 4.4** | -- | -- | 8 | 8.0** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 71 | 42.1 | 71 | 95.5 | -- | -- |
| Prostate gland | 68 | 40.6 | 68 | 92.3 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 46 | 24.7 | 30 | 39.1 | 16 | 14.4** |
| Urinary bladder | 31 | 16.2 | 22 | 28.4 | 9 | 7.5** |
| Kidney and renal pelvis | 15 | 8.5** | 8 | 10.7** | 7 | 6.9** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 8 | 4.7** | 5 | 5.7** | * | # |
| Brain | 7 | 4.3** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 9 | 4.7** | * | # | 6 | 5.8** |
| Thyroid gland | 8 | 4.1** | * | # | 6 | 5.8** |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 35 | 19.5 | 19 | 24.5** | 16 | 15.3** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 32 | 17.7 | 17 | 22.0** | 15 | 13.7** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 6 | 2.9** | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 11 | 6.0** | 7 | 9.1** | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||